Isomorphic Labs
UK-based AI-first drug design and development company
Isomorphic Labs has raised €2.3B across 2 funding rounds from 6 investors, most recently a Series B round in May 2026. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.isomorphiclabs.com ↗
Total raised
€2.3B
€2,347,358,645
Funding rounds
2
Investors
6
distinct backers
Active since
2025-03
latest 2026-05
Funding by year
EUR raised per year · 2026 YTDIsomorphic Labs — funding by year — interactive chart.
Data table
| Isomorphic Labs — funding by year | |
|---|---|
| 2025 | €555M |
| 2026 | €1.8B |
Signals
High confidenceRaise-next likelihood42
base rate 48% for Series B
- ▼ Raised very recently
- ▲ Up-round momentum
Exit likelihood25
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▼ Young (<3y)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-05-13 | Series B | €1.8B | Alphabet,CapitalG,GV,Temasek,Thrive Capital,UK Sovereign AI Fund | View deal → |
| 2025-03-31 | Other | €555M | Alphabet,GV,Thrive Capital | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData